- Cited by
- 6 March 2023 | Psychological Medicine, Vol. 149
- 14 January 2023 | World Psychiatry, Vol. 22, No. 1
- The Lancet Psychiatry, Vol. 10, No. 2
- 10 February 2023 | International Journal of Molecular Sciences, Vol. 24, No. 4
- 30 November 2022 | BMC Medicine, Vol. 20, No. 1
- Angelica Ronald,
Ph.D. , and - Oliver Pain,
Ph.D.
1 November 2022 | American Journal of Psychiatry, Vol. 179, No. 11- Angelica Ronald,
- Ned H. Kalin,
M.D.
1 November 2022 | American Journal of Psychiatry, Vol. 179, No. 11- Ned H. Kalin,
The authors thank the research participants, the employees, and the researchers of the Schizophrenia, Depression, Bipolar Disorder, and ADHD Working Groups of the Psychiatric Genomics Consortium, 23andMe, UK Biobank, CTG, SSGAC, and GIANT for making this research possible. This work was partly performed on the TSD (Tjeneste for Sensitive Data) facilities, owned by the University of Oslo and operated and developed by the TSD service group at the University of Oslo, IT Department (USIT). Computations were also performed on resources provided by UNINETT Sigma2, the National Infrastructure for High-Performance Computing and Data Storage in Norway. The authors gratefully acknowledge support from NIH (NS057198, EB000790, 1R01MH124839), the Research Council of Norway (229129, 213837, 223273, 324252, 248980), the South-East Norway Regional Health Authority (2017-112, 2019-108), and KG Jebsen Stiftelsen (SKGJ-MED-021). This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement nos. 847776, 964874, and 801133 (Marie Skłodowska-Curie grant agreement).